Does FILGRASTIM Cause Neoplasm recurrence? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Neoplasm recurrence have been filed in association with FILGRASTIM (NYPOZI txid). This represents 0.2% of all adverse event reports for FILGRASTIM.
36
Reports of Neoplasm recurrence with FILGRASTIM
0.2%
of all FILGRASTIM reports
6
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm recurrence From FILGRASTIM?
Of the 36 reports, 6 (16.7%) resulted in death, 5 (13.9%) required hospitalization.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM Cause?
Off label use (1,930)
Febrile neutropenia (1,570)
Neutropenia (1,431)
Death (1,213)
Pyrexia (1,085)
Diarrhoea (739)
Nausea (718)
Bone pain (706)
Thrombocytopenia (697)
Anaemia (626)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which FILGRASTIM Alternatives Have Lower Neoplasm recurrence Risk?
FILGRASTIM vs FILGRASTIM-AAFI
FILGRASTIM vs FILGRASTIM-SNDZ
FILGRASTIM vs FINASTERIDE
FILGRASTIM vs FINASTERIDE\TAMSULOSIN
FILGRASTIM vs FINERENONE